188 related articles for article (PubMed ID: 12788184)
1. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy.
Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana H; Furutani K; Ogawa K
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):769-77. PubMed ID: 12788184
[TBL] [Abstract][Full Text] [Related]
2. Clinical assessment by MRI for patients with stage II cervical carcinoma treated by radiation alone in multicenter analysis: are all patients with stage II disease suitable candidates for chemoradiotherapy?
Kodaira T; Fuwa N; Kamata M; Furutani K; Kuzuya K; Ogawa K; Toita T; Sasaoka M; Nomoto Y
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):627-36. PubMed ID: 11849783
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation using magnetic resonance imaging for patients with stage III cervical carcinoma treated by radiation alone in multicenter analysis: its usefulness and limitations in clinical practice.
Kodaira T; Fuwa N; Toita T; Nomoto Y; Kuzuya K; Tachibana K; Furutani K; Ogawa K
Am J Clin Oncol; 2003 Dec; 26(6):574-83. PubMed ID: 14663375
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in definitive radiotherapy of uterine cervical cancer.
Yalman D; Aras AB; Ozkök S; Duransoy A; Celik OK; Ozsaran Z; Haydaroğlu A
Eur J Gynaecol Oncol; 2003; 24(3-4):309-14. PubMed ID: 12807246
[TBL] [Abstract][Full Text] [Related]
5. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
Li X; Wei LC; Zhang Y; Zhao LN; Li WW; Ping LJ; Dang YZ; Hu J; Shi M
Int J Gynecol Cancer; 2016 Oct; 26(8):1472-9. PubMed ID: 27400321
[TBL] [Abstract][Full Text] [Related]
6. Tumor diameter/volume and pelvic node status assessed by magnetic resonance imaging (MRI) for uterine cervical cancer treated with irradiation.
Toita T; Kakinohana Y; Shinzato S; Ogawa K; Yoshinaga M; Iraha S; Higashi M; Sakumoto K; Kanazawa K; Sawada S
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):777-82. PubMed ID: 10098432
[TBL] [Abstract][Full Text] [Related]
7. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
8. Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.
Barillot I; Horiot JC; Maingon P; Truc G; Chaplain G; Comte J; Brenier JP
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):189-200. PubMed ID: 10924989
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy.
Kapp KS; Stuecklschweiger GF; Kapp DS; Poschauko J; Pickel H; Lahousen M; Hackl A
Int J Radiat Oncol Biol Phys; 1998 Oct; 42(3):531-40. PubMed ID: 9806511
[TBL] [Abstract][Full Text] [Related]
10. Tumor volume and uterine body invasion assessed by MRI for prediction of outcome in cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim H; Kim W; Lee M; Song E; Loh JJ
Jpn J Clin Oncol; 2007 Nov; 37(11):858-66. PubMed ID: 18037686
[TBL] [Abstract][Full Text] [Related]
11. Postoperative radiation therapy for stage IB-IIB carcinoma of the cervix with poor prognostic factors.
Uno T; Ito H; Itami J; Yasuda S; Isobe K; Hara R; Sato T; Minoura S; Shigematsu N; Kubo A
Anticancer Res; 2000; 20(3B):2235-9. PubMed ID: 10928184
[TBL] [Abstract][Full Text] [Related]
12. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
[TBL] [Abstract][Full Text] [Related]
13. Prospective multi-institutional study of definitive radiotherapy with high-dose-rate intracavitary brachytherapy in patients with nonbulky (<4-cm) stage I and II uterine cervical cancer (JAROG0401/JROSG04-2).
Toita T; Kato S; Niibe Y; Ohno T; Kazumoto T; Kodaira T; Kataoka M; Shikama N; Kenjo M; Tokumaru S; Yamauchi C; Suzuki O; Sakurai H; Numasaki H; Teshima T; Oguchi M; Kagami Y; Nakano T; Hiraoka M; Mitsuhashi N
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e49-56. PubMed ID: 21470794
[TBL] [Abstract][Full Text] [Related]
14. Differences in outcome for cervical cancer patients treated with or without brachytherapy.
Karlsson J; Dreifaldt AC; Mordhorst LB; Sorbe B
Brachytherapy; 2017; 16(1):133-140. PubMed ID: 27836496
[TBL] [Abstract][Full Text] [Related]
15. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
[TBL] [Abstract][Full Text] [Related]
16. An audit of the treatment of carcinoma of the uterine cervix using external beam radiotherapy and a single line source brachytherapy technique.
Tan LT; Jones B; Gee A; Kingston RE
Br J Radiol; 1997 Dec; 70(840):1259-69. PubMed ID: 9505845
[TBL] [Abstract][Full Text] [Related]
17. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
[TBL] [Abstract][Full Text] [Related]
18. Postoperative radiotherapy in early stage carcinoma of the uterine cervix: treatment results and prognostic factors.
Yeh SA; Wan Leung S; Wang CJ; Chen HC
Gynecol Oncol; 1999 Jan; 72(1):10-5. PubMed ID: 9889023
[TBL] [Abstract][Full Text] [Related]
19. Figo IIIB squamous cell carcinoma of the cervix: an analysis of prognostic factors emphasizing the balance between external beam and intracavitary radiation therapy.
Logsdon MD; Eifel PJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):763-75. PubMed ID: 10098431
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment tumor diameter/volume and pelvic lymph node status assessed by magnetic resonance imaging for uterine cervical carcinoma treated with concurrent chemotherapy and radiotherapy.
Kim HJ; Kim WC
J Obstet Gynaecol Res; 2008 Aug; 34(4):529-37. PubMed ID: 18946937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]